About the Technical Reference Group

The Technical Reference Group (TRG) provides strategic advice to inform the Health Security Initiative’s priorities, policies and investment decisions.

TRG members have experience and expertise across a broad range of fields relevant to the Initiative. These include health policy and systems research, medical research, infectious disease surveillance and control, and international development programming.

Members have broad international professional networks and extensive experience with international organisations including the World Bank, the World Health Organisation and the Global Fund to Fight AIDS, Tuberculosis and Malaria.

TRG members will meet as a group twice a year and individuals will also provide their expertise on specific issues on request. Members will help to shape the initiative, review its progress, recommend adjustments as required, and amplify its reach and impact by calling on their networks.

Read the Technical Reference Group Terms of Reference [Word 28 KB]

Technical Reference Group member profiles

Associate Professor Helen Evans AO

Associate Professor Helen Evans AO

Helen Evans AO served as Deputy CEO at Gavi, The Vaccine Alliance based in Geneva from 2009 until her retirement in 2014. Prior to joining Gavi, she served as Deputy Executive Director at the Global Fund to Fight AIDS, Tuberculosis and Malaria, also based in Geneva, between 2005 and 2009. She has a depth of experience in national and global health policy and strategy development, infectious diseases and working in public private partnerships to deliver results. In the early 1990s Helen managed the National Communicable Diseases Program in the Australian Department of Health. For the seven years prior to moving to Geneva she headed up the Australian Government Office for Aboriginal and Torres Strait Islander Health.

Now living in Melbourne she currently has an honorary appointment as Associate Professor at the Nossal Institute for Global Health at the University of Melbourne, is a board member of The Fred Hollows Foundation, the Burnet Institute, and the Global Health Alliance Melbourne and is a member of the Technical Evaluation and Review Group (TERG) of the Global Fund to Fight AIDS, Tuberculosis and Malaria.

Professor John MacKenzie AO

Professor John MacKenzie AO

Professor John Mackenzie retired in 2008 after holding professorial appointments at Curtin University, The University of Queensland and The University of Western Australia. He is co-founder and Vice-Chair of the One Health Platform, a non-profit foundation based in Belgium, and Editor-in-Chief of the journal, One Health. He has been a consultant to the World Health Organization (WHO) since 1982, and has been closely involved with establishing the Global Outbreak Alert and Response Network and the Asia Pacific Strategy for Emerging Diseases. He serves on the Roster of Experts of the WHO's International Health Regulations (IHR), and in 2009-10 was the Chair of the first IHR Emergency Committee for Pandemic H1N1 influenza, He was elected to the Australian Academy of Technological Sciences and Engineering (ATSE); as a Fellow of the American Academy of Microbiology; and Secretary-General of the International Union of Microbiological Sciences. In 2002, he was appointed as Officer in the Order of Australia for services to public health research and to education. In 2005 he was the inaugural recipient of the Academy of Science Malaysia's Mahathir Science Award for Excellence in Tropical Research. His research interests have included mosquito-borne viral diseases, emerging zoonoses, and aspects of global health security.

Professor Barbara McPake

Professor Barbara McPake

Professor Barbara McPake (BM) [PhD (1993), BA Economics (1983)] is a health economist specialising in health policy and health systems research. She has over 30 years of experience in these areas based in three UK university departments before moving to Australia in 2014. BM is the current Director of the Nossal Institute for Global Health, University of Melbourne, and a Professor of Global Health. She has undertaken a substantial portfolio of research work in the areas of health economics, health policy, health systems and human resources for health.

BM has been a leading member of a series of DFID research programmes including three successive Health Economics and Financing Programmes (1991-2005) and was Programme Director of the Health Systems Development Knowledge Programme (2001-6), all commissioned while she was at the London School of Hygiene and Tropical Medicine. In all these programmes she focused on applying economic perspectives to overcoming the difficulties in extending the reach of health systems to the poorest. From 2011-2017, she was one of two Research Directors of the ReBuild Research Programme Consortium. Also funded by DFID, ReBuild focuses on the lessons to be learned from the re-establishment of health systems in post-conflict settings and is working with partners in Zimbabwe, Uganda, Sierra Leone and Cambodia.

Dr Robert Condon

Dr Robert Condon

Dr Rob Condon is a Public Health Physician with additional qualifications in Tropical Medicine, Applied Epidemiology and Aviation Medicine.

He works closely with governments and development partners in countries of the Pacific Community and in South East Asia to support health policy and systems, health workforce development, strengthening of capacity for the delivery of preventive and clinical health care services, and the overall effectiveness and efficiency of aid and development interventions.

His work on preventive interventions includes supporting better outcomes for communicable disease control (including malaria and other vector-borne diseases, tuberculosis, HIV infection and the detection and management of outbreaks of infectious disease); the emerging interface between communicable and non-communicable diseases in the Pacific; and the laboratory systems to support these programs.

He provides expert advice to the World Health Organization and the Pacific Community on a variety of public health, health system and disease control issues, and to the Australian and New Zealand aid programs on their health sector investments in countries of the Asia-Pacific region. He had a central role with WHO in the response to the outbreak of severe acute respiratory syndrome (SARS) in Asia in 2003.

Professor Guy Thwaites

Professor Guy Thwaites

Professor Guy Thwaites is Director of the Oxford University Clinical Research Unit and Wellcome Trust Major Overseas Programme in Viet Nam; Professor of Infectious Diseases at the University of Oxford; and a Honorary Consultant in Infectious Diseases and Clinical Microbiology at Guy’s and St. Thomas’ NHS Foundation trust.

Guy qualified from Cambridge University and the United Medical and Dental schools of Guy’s and St Thomas’ and trained in Infectious Diseases and Clinical Microbiology in Brighton, the Oxford University Clinical Research Unit (OUCRU) in Vietnam, Imperial College London, and the Hospital for Tropical Diseases in London. Guy’s research interests focus on the management of severe bacterial infections, especially those caused by Staphylococcus aureus and Mycobacterium tuberculosis.

Professor Tania Sorrell

Professor Tania Sorrell

Professor Tania Sorrell is Professor of Clinical Infectious Diseases, Director of the Marie Bashir Institute for infectious Diseases and Biosecurity and Deputy Dean, Sydney Medical School, the University of Sydney, Australia; Director of the Centre for Infectious Diseases and Microbiology, Westmead Institute for Medical Research, Westmead, NSW; and Service Director, Infectious Diseases and Sexual Health, Western Sydney Local Health District.
Tania has had a longstanding clinical interest in mycology and infections in the immunocompromised host and a more recent interest in emerging infectious diseases. Her research has focused on the pathogenesis of fungal infections, emerging fungal diseases, new antifungal drug development, new diagnostics and clinical trials of antifungal diagnostic and treatment strategies. She has served on state and national advisory committees in Infectious Diseases and therapeutics and the Research and Human Ethics Committees of NHMRC.

Professor Bart Currie

Professor Bart Currie

Professor Bart Currie leads the Tropical and Emerging Infectious Diseases team of the Global and Tropical Health Division at Menzies. He is also an infectious diseases physician at the Royal Darwin Hospital and since 2000 Professor in Medicine at the Northern Territory Medical Program through Flinders University. He is Adjunct Professorial Fellow, Charles Darwin University and Adjunct Professor, College of Public Health, Medical and Veterinary Sciences, James Cook University. He is Director of RHD Australia; the National Coordination Unit for Australia's Rheumatic Fever Strategy and also leads the new NHMRC-funded Tropical Disease Research Regional Collaboration Initiative (HOT NORTH).

Bart's passion is coordinating links between clinicians, public health colleagues and other service providers, laboratory scientists and community. His research has involved improving prevention and treatment of specific illnesses; through a better understanding of the epidemiology and underlying disease processes, with development of diagnostic and treatment guidelines.

Mr Mark Sullivan

Mr Mark Sullivan

Mr Mark Sullivan is the current CEO of Medicines Development Ltd, which he founded in 2006. He is responsible for strategy, project management and implementation of clinical trials, including first-in-human, proof of concept, phase II, global phase III, phase IIIb design and implementation, and phase IV.
Mark has a clinical research background with over 20 years’ experience in the development of small molecules, therapeutic and prophylactic vaccines and microbicides. This experience includes 10 years with Glaxo (now GSK) at their research and development headquarters in London, United Kingdom, two years with Gilead Sciences at their head office in San Francisco, USA and three years at University of New South Wales as Chief Operating Officer for HIV Vaccines. Mark’s current areas of interest in global health include the preclinical and clinical development of four products and the in-licensing of IP for use in developing countries.

Last Updated: 13 September 2017